NextCure, Inc. Common Stock (NXTC) is a publicly traded Healthcare sector company. As of May 21, 2026, NXTC trades at $9.65 with a market cap of $33.41M and a P/E ratio of -0.49. NXTC moved +0.88% today. Year to date, NXTC is -29.08%; over the trailing twelve months it is +58.09%. Its 52-week range spans $2.69 to $19.20. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces NXTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NextCure, Inc. Common Stock (NXTC) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NXTC moved +0.88% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $9.65 |
| Market Cap | $33.41M |
| P/E Ratio | -0.49 |
| EPS | $-19.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.20 |
| 52-Week Low | $2.69 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-55.84M |
| Gross Margin | 0.00% |
1 analysts cover NXTC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.